164 related articles for article (PubMed ID: 22360645)
21. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
[TBL] [Abstract][Full Text] [Related]
22. Phosphate kinetics during high-flux hemodialysis.
DeSoi CA; Umans JG
J Am Soc Nephrol; 1993 Nov; 4(5):1214-8. PubMed ID: 8305649
[TBL] [Abstract][Full Text] [Related]
23. What is good about PD + HD combined therapy.
Yamashita AC; Tomisawa N
Hemodial Int; 2011 Oct; 15 Suppl 1():S15-21. PubMed ID: 22093595
[TBL] [Abstract][Full Text] [Related]
24. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
[TBL] [Abstract][Full Text] [Related]
25. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
26. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
27. Residual blood loss in single use dialyzers: effect of different membranes and flux.
Kalocheretis P; Vlamis I; Belesi C; Makriniotou I; Zerbala S; Savidou E; Zorbas S; Arvanitis N; Iatrou C
Int J Artif Organs; 2006 Mar; 29(3):286-92. PubMed ID: 16685672
[TBL] [Abstract][Full Text] [Related]
28. Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling.
Debowska M; Poleszczuk J; Wojcik-Zaluska A; Ksiazek A; Zaluska W
Artif Organs; 2015 Dec; 39(12):1005-14. PubMed ID: 25994493
[TBL] [Abstract][Full Text] [Related]
29. Calcium balance and intact PTH variations during haemodiafiltration.
Argilés A; Mion CM
Nephrol Dial Transplant; 1995 Nov; 10(11):2083-9. PubMed ID: 8643172
[TBL] [Abstract][Full Text] [Related]
30. Phosphate kinetics during different dialysis modalities.
Ratanarat R; Brendolan A; Volker G; Bonello M; Salvatori G; Andrikos E; Yavuz A; Crepaldi C; Ronco C
Blood Purif; 2005; 23(1):83-90. PubMed ID: 15627742
[TBL] [Abstract][Full Text] [Related]
31. Phosphate Removal During Conventional Hemodialysis: a Decades-Old Misconception.
Elias RM; Alvares VRC; Moysés RMA
Kidney Blood Press Res; 2018; 43(1):110-114. PubMed ID: 29414834
[TBL] [Abstract][Full Text] [Related]
32. Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease.
Wyskida K; Witkowicz J; Chudek J; Więcek A
J Ren Nutr; 2012 Jan; 22(1):19-26. PubMed ID: 21620724
[TBL] [Abstract][Full Text] [Related]
33. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.
Heguilén RM; Sciurano C; Bellusci AD; Fried P; Mittelman G; Rosa Diez G; Bernasconi AR
Nephrol Dial Transplant; 2005 Mar; 20(3):591-7. PubMed ID: 15687112
[TBL] [Abstract][Full Text] [Related]
34. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
Krieter DH; Lemke HD; Wanner C
Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
[TBL] [Abstract][Full Text] [Related]
35. Middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
Eloot S; de Vos JY; de Vos F; Hombrouckx R; Verdonck P
Hemodial Int; 2005 Oct; 9(4):399-408. PubMed ID: 16219061
[TBL] [Abstract][Full Text] [Related]
36. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis.
Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J
Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690
[TBL] [Abstract][Full Text] [Related]
37. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
Leypoldt JK
Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
[TBL] [Abstract][Full Text] [Related]
39. Enhanced solute removal with intermittent, in-center, 8-hour nocturnal hemodialysis.
Troidle L; Finkelstein F; Hotchkiss M; Leypoldt JK
Hemodial Int; 2009 Oct; 13(4):487-91. PubMed ID: 19840141
[TBL] [Abstract][Full Text] [Related]
40. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
